Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
2(22%)
Results Posted
50%(1 trials)

Phase Distribution

Ph phase_4
6
67%
Ph phase_2
2
22%
Ph phase_1
1
11%

Phase Distribution

1

Early Stage

2

Mid Stage

6

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
1(11.1%)
Phase 2Efficacy & side effects
2(22.2%)
Phase 4Post-market surveillance
6(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

9

all time

Status Distribution
Active(4)
Completed(2)
Other(3)

Detailed Status

unknown3
Not yet recruiting2
Completed2
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
9
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (11.1%)
Phase 22 (22.2%)
Phase 46 (66.7%)

Trials by Status

not_yet_recruiting222%
completed222%
recruiting222%
unknown333%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DRUG
Total Trials
9